Progress of research on PD-1/PD-L1 in leukemia.

Cao, Huizhen; Wu, Tianyu; Zhou, Xue; Xie, Shuyang; Sun, Hongfang; Sun, Yunxiao; Li, Youjie

Cao, Huizhen; Wu, Tianyu; Zhou, Xue; Xie, Shuyang; Sun, Hongfang; Sun, Yunxiao; Li, Youjie.

Afiliação

Cao H; Department of Pediatrics, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Wu T; Department of Gastrointestinal Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Zhou X; Department of Pediatrics, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Xie S; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, China.
Sun H; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, China.
Sun Y; Department of Pediatrics, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Li Y; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, China.

Front Immunol ; 14: 1265299, 2023.

Article em En | MEDLINE | ID: mdl-37822924

Assuntos

Antígeno B7-H1; Leucemia; Humanos; Antígeno B7-H1/metabolismo; Tolerância Imunológica; Imunoterapia/métodos; Leucemia/terapia; Receptor de Morte Celular Programada 1/metabolismo; Microambiente Tumoral

Palavras-chave

PD-1/PD-L1 mAbs; immunotherapy; leukemia; programmed cell death protein 1; programmed death-ligand 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Antígeno B7-H1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Antígeno B7-H1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article